Buy Tata Elxsi Limited and Sun Pharmaceutical Industries Limited

buy 8

Buy Tata Elxsi Limited:

Tata

Tata Elxsi Ltd has officially announced a consolidated sales of Rs. 477.10 Cr for the third quarter finished on 31-12-2020, which is 10.91% up from its previous quarter sales of Rs. 430.18 Cr and 12.67% up from its previous year same quarter sales of Rs. 423.44 Cr. The company has reported a net profit after tax of Rs. 105.20 Cr in the previous quarter.

Outlook:

Tata Elxsi Ltd: Experts suggested buy call at current market price: Rs. 3,101.60 with a target price: Rs. 3,550; Stoploss: Rs. 2,850.

Buy Sun Pharmaceutical Industries Limited:

buy

Sun Pharmaceutical Industries Ltd has officially announced a consolidated sales of Rs. 8,781.84 Cr for the third quarter finished on 31-12-2020, which is 3.82% up from its previous quarter sales of Rs. 8,458.77 Cr and 9.25% up from its previous year same quarter sales of Rs. 8,038.65 Cr. The company has reported a net profit after tax of Rs. 1,918.11 Cr in the previous quarter.

Outlook:

Sun Pharmaceutical Industries Ltd: Experts suggested buy call at current market price: Rs. 636.75 with a target price: Rs. 660; Stoploss: Rs. 625.

Disclaimer: The perspectives and investment tips are given in this section are the expert’s own and not that of the website or its management. We encourage clients to check with certified experts before taking any position in the stocks/shares mentioned.

Leave a Reply

Your email address will not be published. Required fields are marked *